Jim Heller, co-chair of the firm's Commercial Litigation Department, was quoted in Law 360's article, "Punitives Promise Fiercer Fight In Philly Risperdal Trial." With the possibility of punitive damages on the table for the first time since trials over breast growth in boys who used the antipsychotic drug Risperdal kicked off in Philadelphia four years ago, experts say that jurors in a case slated to open on Tuesday can expect a heightened level of aggression from counsel on both sides. Jim told Law 360, “When you add punitive damages to the mix, it adds a whole new dimension to the litigation. It’s basically a duel between what the defense is going to say the company knew and did, while the plaintiffs are going to say they did nothing other than to maximize profits over safety.”

To read the full article, click here.